ThriveRx Receives Limited Distribution Rights to Gattex (Teduglutide [rDNA

ThriveRx Receives Limited Distribution Rights to Gattex (Teduglutide [rDNA

Filed under: drug treatment program in cincinnati ohio

CINCINNATI, Jan 02, 2013 (BUSINESS WIRE) — ThriveRx, a national specialty pharmacy and infusion services provider, has received limited distribution rights to Gattex(R) (Teduglutide [rDNA origin]) for Injection, for subcutaneous use, from NPS …
Read more on MarketWatch (press release)